Insights

Gain perspectives from experts on various policy issues and therapeutic areas through our Insights series that engages multiple managed care stakeholders in video interviews.

Standard of Care for CSCC
October 14, 2019 – 
Omid Hamid, MD, and Morgana Freeman, MD, discuss primary treatment options for locally advanced or metastatic CSCC and when it’s appropriate to elect for surgery.
Overview of Cutaneous Squamous Cell Carcinoma
October 14, 2019 – 
An overview of cutaneous squamous cell carcinoma (CSCC), including diagnosis, distinguishing CSCC from head and neck cancer, and risk factors for developing advanced disease.
Unmet Needs and Future Directions in ILD
August 28, 2019 – 
Concluding their insights on the management of interstitial lung disease (ILD), experts look forward to the future treatment paradigm.
Treatment Goals and Options for Systemic Sclerosis Interstitial Lung Disease
August 28, 2019 – 
A comprehensive breakdown of treatment strategies for interstitial lung disease in systemic sclerosis.
Systemic Sclerosis and Interstitial Lung Disease
August 21, 2019 – 
Experts reflect on the prevalence and implications of interstitial lung disease in systemic sclerosis.
Treating Progressive Fibrosing Interstitial Lung Disease
August 21, 2019 – 
Specific considerations are given for the identification and management of progressive fibrosing–interstitial lung disease.
Interstitial Lung Disease: Immunosuppressive and Nonpharmacological Options
August 14, 2019 – 
Regarding interstitial lung disease, Alicia M. Hinze, MD, elucidates immunosuppressive approaches and beneficial lifestyle changes.
Treatment Options for Interstitial Lung Disease
August 14, 2019 – 
Shifting their focus to pharmacological management of interstitial lung disease (ILD), experts review approved treatment options.
Interstitial Lung Disease: Guidelines for Therapy
August 08, 2019 – 
Highlights from clinical guidelines and therapeutic goals related to the management of interstitial lung disease (ILD).
Economic Burden of Interstitial Lung Disease
August 08, 2019 – 
An outline of the many factors that play into the direct and indirect costs of interstitial lung disease (ILD).
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.